ATE213940T1 - Parenteral anzuwendende arzneizubereitung enthaltend amiodaron - Google Patents

Parenteral anzuwendende arzneizubereitung enthaltend amiodaron

Info

Publication number
ATE213940T1
ATE213940T1 AT96924037T AT96924037T ATE213940T1 AT E213940 T1 ATE213940 T1 AT E213940T1 AT 96924037 T AT96924037 T AT 96924037T AT 96924037 T AT96924037 T AT 96924037T AT E213940 T1 ATE213940 T1 AT E213940T1
Authority
AT
Austria
Prior art keywords
pct
amiodaron
medicinal preparation
parenteral application
application containing
Prior art date
Application number
AT96924037T
Other languages
English (en)
Inventor
Jean-Claude Gautier
Regine Bellamy
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE213940T1 publication Critical patent/ATE213940T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT96924037T 1995-06-30 1996-06-28 Parenteral anzuwendende arzneizubereitung enthaltend amiodaron ATE213940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507939A FR2735978B1 (fr) 1995-06-30 1995-06-30 Composition pharmaceutique d'amiodarone pour administration parenterale
PCT/FR1996/001010 WO1997002031A1 (fr) 1995-06-30 1996-06-28 Composition pharmaceutique d'amiodarone pour administration parenterale

Publications (1)

Publication Number Publication Date
ATE213940T1 true ATE213940T1 (de) 2002-03-15

Family

ID=9480596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96924037T ATE213940T1 (de) 1995-06-30 1996-06-28 Parenteral anzuwendende arzneizubereitung enthaltend amiodaron

Country Status (14)

Country Link
US (1) US6143778A (de)
EP (1) EP0835105B1 (de)
JP (1) JP3137987B2 (de)
AT (1) ATE213940T1 (de)
AU (1) AU6462596A (de)
BR (1) BR9609666A (de)
CA (1) CA2222304C (de)
DE (1) DE69619673T2 (de)
ES (1) ES2174083T3 (de)
FR (1) FR2735978B1 (de)
MX (1) MX9710206A (de)
NO (1) NO317061B1 (de)
WO (1) WO1997002031A1 (de)
ZA (1) ZA965525B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861539B1 (en) 1995-03-10 2005-03-01 G. D. Searle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US7339078B2 (en) * 1995-03-10 2008-03-04 G.D. Searle Llc Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
FR2764800B1 (fr) 1997-06-23 1999-09-10 Sanofi Sa Composition pharmaceutique solide contenant des derives de benzofuranne
US6479541B1 (en) 2000-03-30 2002-11-12 Baxter International Amiodarone-containing parenteral administration
US6646195B1 (en) * 2000-04-12 2003-11-11 Microsoft Corporation Kernel-mode audio processing modules
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20020143051A1 (en) 2001-03-29 2002-10-03 Doty Mark J. Premixed amiodarone parenteral solution and method for making the same
BR0208475A (pt) * 2001-03-29 2004-03-09 Baxter Int Solução para administração intravenosa, e, método para a produção de uma solução de amiodarona adequada para administração intravenosa
US7244703B2 (en) * 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CA2451839C (en) * 2001-06-22 2013-08-06 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions comprising peptides and permeation enhancers
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
US6869939B2 (en) * 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
PL2279729T3 (pl) * 2003-07-17 2017-02-28 Banner Life Sciences Llc Preparaty o kontrolowanym uwalnianiu
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
KR100893512B1 (ko) 2004-04-26 2009-04-16 미쓰비시 마테리알 가부시키가이샤 폐수 처리방법 및 폐수 처리장치
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
JP5584486B2 (ja) * 2009-02-16 2014-09-03 株式会社クラレ バラスト水製造装置
EP2335686A1 (de) 2009-12-21 2011-06-22 LEK Pharmaceuticals d.d. Wässrige intravenöse Nanosuspension mit minimalen Nebenwirkungen
WO2011156481A2 (en) 2010-06-11 2011-12-15 Baxter International Inc. Formulations including amiodarone and salts thereof and methods of their manufacture and use
US10556256B2 (en) * 2014-05-28 2020-02-11 Takeda Pharmaceutical Company Limited Antibacterial water
WO2018175271A1 (en) * 2017-03-24 2018-09-27 Merck Sharp & Dohme Corp. Formulation for parenteral administration
US20220016070A1 (en) * 2020-07-17 2022-01-20 Good Health, Llc Premixed, ready to use pharmaceutical compositions of amiodarone
CN112472668B (zh) * 2020-10-29 2023-02-28 太阳升(亳州)生物医药科技有限公司 用于制备盐酸胺碘酮注射液的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234949A (en) * 1992-04-01 1993-08-10 Academic Pharmaceuticals, Inc. Parenteral solutions containing amiodarone in acetate buffer solution

Also Published As

Publication number Publication date
DE69619673T2 (de) 2002-11-14
CA2222304C (fr) 2002-09-17
NO976125D0 (no) 1997-12-29
US6143778A (en) 2000-11-07
CA2222304A1 (fr) 1997-01-23
EP0835105B1 (de) 2002-03-06
MX9710206A (es) 1998-03-31
AU6462596A (en) 1997-02-05
DE69619673D1 (de) 2002-04-11
JPH10510297A (ja) 1998-10-06
FR2735978A1 (fr) 1997-01-03
FR2735978B1 (fr) 1997-09-19
JP3137987B2 (ja) 2001-02-26
NO317061B1 (no) 2004-08-02
EP0835105A1 (de) 1998-04-15
BR9609666A (pt) 1999-05-25
NO976125L (no) 1998-02-26
ES2174083T3 (es) 2002-11-01
WO1997002031A1 (fr) 1997-01-23
ZA965525B (en) 1997-12-29

Similar Documents

Publication Publication Date Title
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
EG20540A (en) New emulsion formulation
BRPI0008228B8 (pt) composição farmacêutica contendo n-benzoil estaurosporina e agentes solubilizantes
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
BR9509975A (pt) Formulação farmacêutica
SE8804628A (de)
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION
ES2197781A1 (es) Composiciones farmaceuticas liquidas de base acuosa en forma de suspension para la administracion por via oral de ibuprofeno.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification